Catalyst Wire Dossier Catalyst Wire Dossier

Asciminib

asciminib · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for Asciminib, covering 2025-02-14 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP [Phase 2]

See pricing